Concepedia

Neil Johnson

NJ

Statistics

Publications

35

Citations

4K

H-Index

26

Active since

1976

Affiliations

Fox Chase Cancer Center(Current)

Temple University

University of Washington

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Neil Johnson is an author at Fox Chase Cancer Center specializing in molecular oncology, dna repair, and parp inhibition.

Publications per year

1976–2024

35

Publications

35

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models

Hyoung Kim, Haineng Xu, Erin George et al. · Nature Communications · 2020 · 369 citations · Full text

Medicine, Oncology, Pharmacology +17

Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency

Ke Cong, Min Peng, Arne Nedergaard Kousholt et al. · Molecular Cell · 2021 · 322 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +17

Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition

Neil Johnson, Yuchen Li, Zandra E. Walton et al. · Nature Medicine · 2011 · 306 citations

Medicine, Cancer Biology, Oncology +15

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Olga Kondrashova, Monique Topp, Ksenija Nesic et al. · Nature Communications · 2018 · 292 citations · Full text

Medicine, Molecular Genetics, Oncology +17

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

Shawn F. Johnson, Cristina Cruz, Ann Katrin Greifenberg et al. · Cell Reports · 2016 · 286 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–5 of 35